Kim HD - Search Results

1

Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxP3- CD4+ T Cells in Biliary Tract Cancer.

Kim HD, Kim JH, Ryu YM, Kim D, Lee S, Shin J, Hong SM, Kim KH, Jung DH, Song GW, Hwang DW, Lee JH, Song KB, Ryoo BY, Jeong JH, Kim KP, Kim SY, Yoo C. Kim HD, et al. Among authors: kim d, kim kp, kim sy, kim kh, kim jh. Cancer Res Treat. 2021 Jan;53(1):162-171. doi: 10.4143/crt.2020.704. Epub 2020 Aug 31. Cancer Res Treat. 2021. PMID: 32878426 Free PMC article.

2

Clinical validity of Metroticket calculator in transplant patients undergoing prior chemoembolization for hepatocellular carcinoma.

Kim HD, Song GW, Shim JH, Han S, An J, Moon DB, Kim KM, Lim YS, Ko GY, Hwang S, Lee HC, Yu E, Sung KB, Lee SG. Kim HD, et al. Among authors: kim km. Hepatol Int. 2017 Mar;11(2):209-219. doi: 10.1007/s12072-017-9785-2. Epub 2017 Jan 31. Hepatol Int. 2017. PMID: 28144812

3

Association Between Expression Level of PD1 by Tumor-Infiltrating CD8⁺ T Cells and Features of Hepatocellular Carcinoma.

Kim HD, Song GW, Park S, Jung MK, Kim MH, Kang HJ, Yoo C, Yi K, Kim KH, Eo S, Moon DB, Hong SM, Ju YS, Shin EC, Hwang S, Park SH. Kim HD, et al. Among authors: kim mh, kim kh. Gastroenterology. 2018 Dec;155(6):1936-1950.e17. doi: 10.1053/j.gastro.2018.08.030. Epub 2018 Aug 24. Gastroenterology. 2018. PMID: 30145359

4

4-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8⁺ T Cells in Hepatocellular Carcinoma.

Kim HD, Park S, Jeong S, Lee YJ, Lee H, Kim CG, Kim KH, Hong SM, Lee JY, Kim S, Kim HK, Min BS, Chang JH, Ju YS, Shin EC, Song GW, Hwang S, Park SH. Kim HD, et al. Among authors: kim hk, kim cg, kim s, kim kh. Hepatology. 2020 Mar;71(3):955-971. doi: 10.1002/hep.30881. Epub 2019 Oct 18. Hepatology. 2020. PMID: 31353502 Free PMC article.

5

PD-1 blockade-unresponsive human tumor-infiltrating CD8⁺ T cells are marked by loss of CD28 expression and rescued by IL-15.

Kim KH, Kim HK, Kim HD, Kim CG, Lee H, Han JW, Choi SJ, Jeong S, Jeon M, Kim H, Koh J, Ku BM, Park SH, Ahn MJ, Shin EC. Kim KH, et al. Among authors: kim h, kim hk, kim cg, kim hd. Cell Mol Immunol. 2021 Feb;18(2):385-397. doi: 10.1038/s41423-020-0427-6. Epub 2020 Apr 24. Cell Mol Immunol. 2021. PMID: 32332901 Free PMC article.

6

Regorafenib in patients with advanced Child-Pugh B hepatocellular carcinoma: A multicentre retrospective study.

Kim HD, Bang Y, Lee MA, Kim JW, Kim JH, Chon HJ, Kang B, Kang MJ, Kim I, Cheon J, Hwang JE, Kang JH, Byeon S, Hong JY, Ryoo BY, Lim HY, Yoo C. Kim HD, et al. Among authors: kim i, kim jw, kim jh. Liver Int. 2020 Oct;40(10):2544-2552. doi: 10.1111/liv.14573. Epub 2020 Jul 9. Liver Int. 2020. PMID: 32563213

7

Distinct tumor immune microenvironments in primary and metastatic lesions in gastric cancer patients.

Son SM, Woo CG, Kim DH, Yun HY, Kim H, Kim HK, Yang Y, Kwon J, Kwon M, Kim TY, Kim HD, Koh JY, Park SH, Shin EC, Han HS. Son SM, et al. Among authors: kim h, kim hk, kim dh, kim ty, kim hd. Sci Rep. 2020 Aug 31;10(1):14293. doi: 10.1038/s41598-020-71340-z. Sci Rep. 2020. PMID: 32868848 Free PMC article.

8

TOX-expressing terminally exhausted tumor-infiltrating CD8⁺ T cells are reinvigorated by co-blockade of PD-1 and TIGIT in bladder cancer.

Han HS, Jeong S, Kim H, Kim HD, Kim AR, Kwon M, Park SH, Woo CG, Kim HK, Lee KH, Seo SP, Kang HW, Kim WT, Kim WJ, Yun SJ, Shin EC. Han HS, et al. Among authors: kim h, kim ar, kim hk, kim wj, kim hd, kim wt. Cancer Lett. 2021 Feb 28;499:137-147. doi: 10.1016/j.canlet.2020.11.035. Epub 2020 Nov 27. Cancer Lett. 2021. PMID: 33249194

9

Prognostic Stratification of Patients with Burkitt Lymphoma Using Serum β2-microglobulin Levels.

Kim HD, Cho H, Kim S, Lee K, Kang EH, Park JS, Park CS, Huh J, Ryu JS, Lee SW, Yoon DH, Kim SJ, Ko YH, Kim WS, Suh C. Kim HD, et al. Among authors: kim s, kim sj, kim ws. Cancer Res Treat. 2021 Jul;53(3):847-856. doi: 10.4143/crt.2020.1060. Epub 2020 Dec 17. Cancer Res Treat. 2021. PMID: 33332932 Free PMC article.

10

Implication of CD69⁺ CD103⁺ tissue-resident-like CD8⁺ T cells as a potential immunotherapeutic target for cholangiocarcinoma.

Kim HD, Jeong S, Park S, Lee YJ, Ju YS, Kim D, Song GW, Lee JH, Kim SY, Shin J, Shin EC, Hwang S, Yoo C, Park SH. Kim HD, et al. Among authors: kim d, kim sy. Liver Int. 2021 Apr;41(4):764-776. doi: 10.1111/liv.14814. Epub 2021 Feb 23. Liver Int. 2021. PMID: 33548061

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,200 results

Search Page